Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PD-1 mAb
DRUG
2 trials
Sponsors
The First Affiliated Hospital of Guangdong Pharmaceutical University
, Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions
Carcinoma, Hepatocellular
Lung Neoplasm Malignant
Non-small Cell Lung Cancer
Phase 1
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
NCT03525782
The First Affiliated Hospital of Guangdong Pharmaceutical University
Lung Neoplasm Malignant, Non-small Cell Lung Cancer
Start: 2018-02-01
End: 2022-01-31
Target: 60
Updated: 2018-05-16
Phase 2
Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma
NCT03732547
Second Affiliated Hospital, School of Medicine, Zhejiang University
Carcinoma, Hepatocellular
Start: 2018-10-22
End: 2023-10-22
Target: 60
Updated: 2018-11-16
Related Papers
Anti-MUC1 CAR-T cells combined with PD-1 knockout engineered T cells for patients with non-small cell lung cancer (NSCLC): A pilot study
Annals of Oncology
2018-12-01
11 citations